Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenmai injection for COPD complicated by chronic pulmonary heart disease
ChiCTR-TRC-12002889Phase 4Completed
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of shenmai injection in chronic obstructive pulmonary disease (COPD) and chronic cor pulmonale (2 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoints: Change in symptoms including shortness of breath, palpitations, and dry mouth, Change in qi and yin deficiency syndrome and 1 more. Started Aug 2012; status: completed.
02
Drugs
shenmai injection
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic cor pulmonale
Beyond the preview
Go deeper on ChiCTR-TRC-12002889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002889.